Real-World Experience of Adalimumab in the Treatment of Hidradenitis Suppurativa
Published: 7 December 2020| Version 1 | DOI: 10.17632/pfz95dbvgm.1
Contributors:
,
Alyce Anderson,
Caroline Kettering,
Alicia Mizes,
Timothy Patton
Description
Supplemental Data on Reasons for Adalimumab Treatment Discontinuation and Secondary Treatment Initiated After Adalimumab Treatment Failure
Files
Institutions
University of Pittsburgh Medical Center
Categories
Hidradenitis Suppurativa